554 related articles for article (PubMed ID: 28545441)
1. Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients.
Spinelli FR; Pecani A; Ciciarello F; Colasanti T; Di Franco M; Miranda F; Conti F; Valesini G; Alessandri C
BMC Musculoskelet Disord; 2017 May; 18(1):214. PubMed ID: 28545441
[TBL] [Abstract][Full Text] [Related]
2. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.
Ajeganova S; van Steenbergen HW; Verheul MK; Forslind K; Hafström I; Toes RE; Huizinga TW; Svensson B; Trouw LA; van der Helm-van Mil AH
Ann Rheum Dis; 2017 Jan; 76(1):112-118. PubMed ID: 27117699
[TBL] [Abstract][Full Text] [Related]
3. Brief report: lack of replication of an association between anti-citrullinated fibrinogen and subclinical atherosclerosis in patients with rheumatoid arthritis.
Montes A; Corrales A; Calaza M; Lopez-Mejias R; Parra JA; González-Gay MA; González A
Arthritis Rheumatol; 2015 Nov; 67(11):2861-5. PubMed ID: 26246227
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases.
Pecani A; Alessandri C; Spinelli FR; Priori R; Riccieri V; Di Franco M; Ceccarelli F; Colasanti T; Pendolino M; Mancini R; Truglia S; Barbati C; Vomero M; Sabatinelli D; Morello F; Valesini G; Conti F
Arthritis Res Ther; 2016 Nov; 18(1):276. PubMed ID: 27887639
[TBL] [Abstract][Full Text] [Related]
5. Auto-antibodies do not influence development of atherosclerotic plaques in rheumatoid arthritis.
Pereira I; Laurindo I; Burlingame R; Anjos L; Viana V; Leon E; Vendramini M; Borba E
Joint Bone Spine; 2008 Jul; 75(4):416-21. PubMed ID: 18457983
[TBL] [Abstract][Full Text] [Related]
6. Anti-carbamylated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: lack of correlation with anti-cyclic citrullinated protein antibodies and rheumatoid factor.
Alessandri C; Bartosiewicz I; Pendolino M; Mancini R; Colasanti T; Pecani A; Morello F; Mastrangelo A; Sabatinelli D; Riccieri V; Di Franco M; Ceccarelli F; Perricone C; Conti F; Valesini G
Clin Exp Rheumatol; 2015; 33(6):824-30. PubMed ID: 26411477
[TBL] [Abstract][Full Text] [Related]
7. The Extent of Subclinical Atherosclerosis Is Partially Predicted by the Inflammatory Load: A Prospective Study over 5 Years in Patients with Rheumatoid Arthritis and Matched Controls.
Södergren A; Karp K; Bengtsson C; Möller B; Rantapää-Dahlqvist S; Wållberg-Jonsson S
J Rheumatol; 2015 Jun; 42(6):935-42. PubMed ID: 25877503
[TBL] [Abstract][Full Text] [Related]
8. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis.
Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Toes RE; Trouw LA; van Schaardenburg D
Arthritis Rheum; 2013 Apr; 65(4):911-5. PubMed ID: 23279976
[TBL] [Abstract][Full Text] [Related]
9. Can the ankle brachial pressure index (ABPI) and carotis intima media thickness (CIMT) be new early stage markers of subclinical atherosclerosis in patients with rheumatoid arthritis?
Kurt T; Temiz A; Gokmen F; Adam G; Ozcan S; Ozbudak E; Sacar M
Wien Klin Wochenschr; 2015 Jul; 127(13-14):529-34. PubMed ID: 25777147
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-α, and C-reactive protein are associated with increased carotid intima-media thickness: a cross-sectional analysis of a cohort of rheumatoid arthritis patients without cardiovascular risk factors.
Vázquez-Del Mercado M; Nuñez-Atahualpa L; Figueroa-Sánchez M; Gómez-Bañuelos E; Rocha-Muñoz AD; Martín-Márquez BT; Corona-Sanchez EG; Martínez-García EA; Macias-Reyes H; Gonzalez-Lopez L; Gamez-Nava JI; Navarro-Hernandez RE; Nuñez-Atahualpa MA; Andrade-Garduño J
Biomed Res Int; 2015; 2015():342649. PubMed ID: 25821796
[TBL] [Abstract][Full Text] [Related]
11. Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis.
Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Hamann D; van Schaardenburg D; Toes RE; Trouw LA
Ann Rheum Dis; 2014 Apr; 73(4):780-3. PubMed ID: 24336334
[TBL] [Abstract][Full Text] [Related]
12. Subclinical peripheral arterial disease in rheumatoid arthritis.
Stamatelopoulos KS; Kitas GD; Papamichael CM; Kyrkou K; Zampeli E; Fragiadaki K; Panoulas VF; Mavrikakis M; Sfikakis PP
Atherosclerosis; 2010 Sep; 212(1):305-9. PubMed ID: 20553683
[TBL] [Abstract][Full Text] [Related]
13. Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis.
Challener GJ; Jones JD; Pelzek AJ; Hamilton BJ; Boire G; de Brum-Fernandes AJ; Masetto A; Carrier N; Ménard HA; Silverman GJ; Rigby WFC
J Rheumatol; 2016 Feb; 43(2):273-281. PubMed ID: 26669911
[TBL] [Abstract][Full Text] [Related]
14. Uric acid is independent cardiovascular risk factor, as manifested by increased carotid intima-media thickness in rheumatoid arthritis patients.
Hannawi S; AlSalmi I; Moller I; Naredo E
Clin Rheumatol; 2017 Aug; 36(8):1897-1902. PubMed ID: 28664292
[TBL] [Abstract][Full Text] [Related]
15. Disease Activity, Oxidized-LDL Fraction and Anti-Oxidized LDL Antibodies Influence Cardiovascular Risk in Rheumatoid Arthritis.
Nowak B; Madej M; Łuczak A; Małecki R; Wiland P
Adv Clin Exp Med; 2016; 25(1):43-50. PubMed ID: 26935497
[TBL] [Abstract][Full Text] [Related]
16. Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies.
Nakabo S; Hashimoto M; Ito S; Furu M; Ito H; Fujii T; Yoshifuji H; Imura Y; Nakashima R; Murakami K; Kuramoto N; Tanaka M; Satoh J; Ishigami A; Morita S; Mimori T; Ohmura K
Rheumatology (Oxford); 2017 Jul; 56(7):1217-1226. PubMed ID: 28398552
[TBL] [Abstract][Full Text] [Related]
17. Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study.
Chatterjee Adhikari M; Guin A; Chakraborty S; Sinhamahapatra P; Ghosh A
Semin Arthritis Rheum; 2012 Apr; 41(5):669-75. PubMed ID: 22035626
[TBL] [Abstract][Full Text] [Related]
18. Increased prevalence of carotid artery atherosclerosis in rheumatoid arthritis is artery-specific.
Kobayashi H; Giles JT; Polak JF; Blumenthal RS; Leffell MS; Szklo M; Petri M; Gelber AC; Post W; Bathon JM
J Rheumatol; 2010 Apr; 37(4):730-9. PubMed ID: 20110515
[TBL] [Abstract][Full Text] [Related]
19. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
[TBL] [Abstract][Full Text] [Related]
20. Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors.
Daza L; Aguirre M; Jimenez M; Herrera R; Bollain JJ
Clin Rheumatol; 2007 Apr; 26(4):533-7. PubMed ID: 16758372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
